Environmental toxins and α-synuclein in Parkinson's disease

Molecular Neurobiology

Volumn 31, Issue 1-3, 2005, Pages 273-282

  Liu, Yanying ^a   Yang, Hui ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Environmental toxins; Mitochondria; Oxidative stress; Parkinson's disease; synuclein

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ALPHA SYNUCLEIN; FREE RADICAL; HERBICIDE; NEUROTOXIN; PARAQUAT; PESTICIDE; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; ROTENONE; TOXIN;

BLOOD BRAIN BARRIER; CONFERENCE PAPER; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOPAMINERGIC NERVE CELL; ENVIRONMENTAL FACTOR; HUMAN; MITOCHONDRION; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEIN AGGREGATION; PROTEIN FUNCTION; PROTEIN INTERACTION; SUBSTANTIA NIGRA;

EID: 24644493230     PISSN: 08937648     EISSN: None     Source Type: Journal    
DOI: 10.1385/MN:31:1-3:273     Document Type: Conference Paper

References (68)

1. Goedert M. (2001) Alpha-synuclein and neurodegenerative diseases. Neuroscience 2, 492-501.
2. Dawson T.M. and Dawson V.L. (2003) Molecular pathways of neurodegeneration in Parkinson's disease. Science 302, 819-822.
3. Collier K.S., Maries E., and Kordower J.H. (2002) Etiology of Parkinson's disease: genetics and environment revisited. PNAS 99, 13,972-13,974.
4. Warner T.T. and Schapira A.H.V. (2003) Genetic and environmental factors in the cause of Parkinson's disease. Ann. Neurol. 53 (Suppl. 3), s16-s25.
5. Manning Bog A.B., McCormack A.L., Li J., Uversky B.N., Fink A.L., and Di Monte D.A. (2002) The herbicide paraquat causes up-regulation and aggregation of α-synuclein in mice. J. Biol. Chem. 277, 1641-1644.
6. Isacson O. (2002) Models of repair mechanisms for future treatment modalities of Parkinson's disease. Brain Res. Bull. 57, 839-846.
7. Dauer W., Kholodilov N., Vila M., et al. (2002) Resistance of α-synuclein null mice to the Parkinsonian neurotoxin MPTP. Proc. Natl. Acad. Sci. USA 99, 14,524-14,529.
8. Wang H.M., Shimoji M., Yu S.W., Dawson T.M., and Dawson V. (2003) Apoptosis inducing factor and PARP-mediated injury in the MPTP mouse model of Parkinson's disease. Ann. NY Acad. Sci. 991, 132-139.
9. Beal M.F. (2003) Mitochondria, Oxidative Damage, and Inflammation in Parkinson's disease. Ann. NY Acad. Sci. 991, 120-131.
10. Collier T.J., Collier K.S., Mcguire S., and Sortwell C.E. (2003) Cellular models to study dopaminergic injury responses. Ann. NY Acad. Sci. 991, 140-151.
11. Sherer T.B., Kim J.H., Betarbet R., and Greennmyre J.T. (2003) Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and α-synuclein aggregation. Exp. Neurol. 179, 9-16.
12. Brunk U.T. and Terman A. (2002) The mitochondrial-lysosomal axis theory of aging accumulation of damaged mitochondria as a result of imperfect autophagocytosis. Eur. J. Biochem. 269, 1996-2002.
13. Orth M., Tabrizi S.J., Schapira A.H.V., and Cooper J.M. (2003) α-Synuclein expression in HEK293 cells enhances the mitochondrial sensitive to rotenone. Neurosci. Lett. 351, 29-32.
14. Betarbet R., Sherer T.B., Di Monte D.A., and Greenamyre J.T. (2002) Mechanistic approaches to Parkinson's disease pathogenesis. Brain Pathol. 12, 499-510.
15. Kathleen A., Grire-Zeiss M.A., and Federoff H.J. (2003) Convergent pathobiologic model of Parkinson's disease. Ann. NY Acad. Sci. 991, 152-166.
16. + increases α-synuclein expression and ERK/ MAP-kinase phosphorylation in human neuroblastoma SH-SY5Y cells. Brain Res. 935, 32-39.
17. Mc Naught K.S.P. and Olanow C. (2003) Proteolytic stress: a unifying concept for the etiopathogenesis of Parkinson's disease. Ann. Neurol. 53,(Suppl. 3), s73-s86.
18. Cookson M.R. (2003) Pathways to parkinsonism. Neuron 37, 7-10.
19. Seo J.H., Rah J.C., Choi S.H., et al. (2002) α-Synuclein regulates neuronal survival via Bcl-2 family expression and PI3/Akt kinase pathway. FASEB J. 16, 1826-1829.
20. George J.M. (2001) The synucleins. Genome Biol. 3, 3002.1-3002.6.
21. Ma Q.L., Chan P., Yoshii M., and Uéda K. (2003) α-Synuclein aggregation and neurodegenerative disease. J. Alzheimer's Dis. 5, 139-148.
22. Yu X., Tsunao S., Uéda K., et al. (2001) Characterization of the human α-synuclein gene: genomic structure, transcription start site, promoter region and polymorphisms. J. Alzheimer's Dis. 3, 485-494.
23. Lücking C.B. and Brice A. (2000) Alpha-synuclein and Parkinson's disease. Cell. Mol. Life Sci. 57, 1894-1908.
24. Paxinou E., Chen Q., Giasson Bi W.M., et al. (2001) Induction of alpha-synuclein aggregation by intracellular nitrative insult. J. Neurosci. 21, 8053-8061.
25. Iseki E., Marui W., Sawada H., Uéda K., and Kosaka K. (2000) Accumulation of human α-synuclein in different cytoskeletons in Lewy bodies in brain of dementia with lewy bodies. Neurosci. Lett. 290, 41-44.
26. Saha A.R., Hill J., Utton M.A., et al. (2004) Parkinson's disease (alpha-synuclein) mutations exhibit defective axonal transport in cultured neurons. J. Cell Sci. 117, 1017-1024.
27. Bianco C.L., Ridet J.L., Schneider B.L. Déglon N., and Aebischer P. (2002) α-Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease. PNAS 99, 10,813-10,818.
28. Abeliovich A., Schmitz Y., Farinas I., et al. (2000) Mice Lacking α-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25, 239-252.
29. Goerts J., Manning-Bog A.B., Cormack A.L.M., et al. (2003) Nuclear localization of α-synuclein and its interaction with histones. Biochemistry 42, 8465-8471.
30. Alim M.A., Hossain M.S., Arima K., et al. (2002) Tubulin seeds α-synuclein fibril formation. J. Biol. Chem. 277, 2112-2117.
31. Neystat M., Rzhetskaya M., Holodilov N., and Burke R.E. (2002) Analysis of synphilin-1 and synuclein interactions by yeast two-hybrid β-galactosidase liquid assay. Neurosci. Lett. 325, 119-123.
32. Duda J.E., Lee V.M.Y., and Trojanowski J. (2000) Neuropathology of α-synuclein aggregates new insights into mechanisms of neurodegenerative disease. J. Neurosci. Res. 61, 121-127.
33. Saha A.R., Ninkin N.N., Hanger D.P., and Bham D.A. (2000) Induction of neuronal death by alpha-synuclein. Eur. J. Neurosci. 12, 3073-3077.
34. Conway K.A., Lee S.J., Rochet J.C., et al. (2000) Acceleration of oligomerization not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. Proc. Natl. Acad. Sci. USA 97, 571-576.
35. Spira P.J., Sharpe D.M., Halliday G., Cavanagh J., and Nicholson G.A (2001) Clinical and pathological features of a Parkinsonian syndrome in a family with an Ala53Thr alpha-synuclein mutation. Ann. Neurol. 149, 313-319.
36. Giasson B.I., Duda J.E, Quinn A.M., Zhang B., Trojanowski J.Q., and Lee V.M. (2002) Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein Neuron 34, 521-523.
37. Cristina G.S., Ferrer I., Santidrian A.F., and Barrachina M. (2003) Dopamine induces autophagic cell death and α-synuclein increase in human neuroblastoma SH-SY5Y cells. J. Neurosci. Res. 73, 341-350.
38. Hashimoto M., Rockenstein E., and Masliaii E. (2003) Transgenic models of α-synuclein Pathology past present, and future. Ann. NY Acad. Sci. 991, 171-188.
39. Dawson T.M., Mandir A.S., and Lee M.K. (2002) Animal models of PD: pieces of the same puzzle? Neuron 35, 219-212.
40. Feany M.B. and Bendera W.W. (2000) Drosophila model of Parkinson's disease. Nature 404, 394-398.
41. Sherer T.B., Betarbet R., Stout A.K., et al. (2002) An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered α-synuclein metabolism and oxidative damage. J. Neurosci. 22, 7006-7015.
42. Uversky V.N., Li J., and Fink A.L. (2001) Pesticides directly accelerate the rate of α-synuclein fibril formation: a possible factor in Parkinson's disease. FEBS Lett. 500, 105-108.
43. Masliah E., Rockenstein E., Veinbergs I., et al. (2000) Dopaminergic loss and inclusion body formation in α-synuclein mice: implications for neurodegenerative disorders. Science 287, 1265-1269.
44. Kostrzewa R.M. and Juan S.A. (2003) Novel mechanisms and approaches in the study of neurodegeneration and neuroprotection. Neurotox. Res. 5, 375-384.
45. Betarbet R., Sherer T.B., Mackenzie G., Caucica-Osuna M., Panov A.V., and Greenamgre J.T. (2000) Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3, 1301-1306.
46. Orth M. and Schapira A.H.V. (2002) Mitochondrial involvement in Parkinson's disease. Neurochem. Int. 40, 533-541.
47. Vila M., Vukosavic S., Jackson L.V., Neystat M., Jakowec M., and Przedborski S. (2000) α-Synuclein up-regulation in substantia nigra of dopaminergic neurons following administration of the Parkinsonian toxin MPTP. J. Neurochem. 74, 721-729.
48. Lim K.L., Dawson V., and Dawson T.M. (2003) The cast of molecular characters in Parkinson's disease. Ann. NY Acad. Sci. 991, 80-92.
49. Loo G.V., Saelens X., Gurp M.V., Farlane M.M., Martin S.J., and Vandenabeele P. (2002) The role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet. Cell Death Differ. 9, 1031-1042.
50. Ameisen J.C. (2004) Looking for death at the core of life in the light of evolution. Cell Death Differ. 11, 4-10.
51. Tatton W.G.., Ruth C.R., Brown D., and Tatton N. (2003) Apoptosis in Parkinson's disease: signals for neuronal degradation. Ann. Neurol. 53(Suppl. 3), s61-s72.
52. Hsu L.J., Sagara Y., Arroyo A., et al. (2000) α-Synuclein promotes mitochondrial deficit and oxidative stress. Am. J. Pathol. 2, 401-410.
53. Hashimoto M., Takeda A., Hsu L.J., Takenouchi T., and Masliah E. (1999) Role of cytochrome c as a stimulator of α-synuclein aggregation in lewy body disease. J. Biol. Chem. 274, 28,849-28,852.
54. Yuan J.Y., Lipinski M., and Degterev A. (2003) Diversity in the mechanisms of neuronal cell death. Neuron 40, 401-413.
55. Webb J.L., Ravikumar B., Atkins J., Skepper J.N., and Rubinsztein D.C. (2003) α-Synuclein is degraded by both autophagy and the proteasome. J. Biol. Chem. 278, 25,009-25,013.
56. Stefanis L., Larsen K.E., Rideout H.J., Sulzer D., and Greene L.A. (2001) Expression of A53T mutant but not wild-type alpha-synuclein in PC 12 cells induces alterations of the ubiquitin-dependent degradation system loss of dopamine release and autophagic cell death. J. Neurosci. 21, 9549-9560.
57. Xu J., Kao S.Y., Lee F.J.S., Song W.H., Jin L.W., and Yonkner B.A. (2002) Dopamine dependent neurotoxicity of α-synuclein: a mechanism for selective neurodegeneration in Parkinson's disease. Nat. Med. 8, 600-606.
58. Manning-Bog A.B., McCormack A.L., Purisai M.G.., Bolin L.M., and Di Monte D.A. (2003) α-Synuclein overexpression protects against paraquat-induced neurodegeneration. J. Neurosci. 23, 3095-3099.
59. Rathke-Hartlieb S., Hahle P.J., Neumann M., et al. (2001) Sensitivity to MPTP is not increased in Parkinson's disease-associated mutant α-synuclein transgenic mice. J. Neurochem. 77, 1181-1184.
60. Zhang Y.X., Yang H., Cai Q., et al. (2003) The influence of overexpression α-synuclein EGFP on formation of inclusion and mitochondrial ultrastructure in SH-SY5Y cells in vitro. Chin. J. Neuroanal. 19, 251-256.
61. Dacosta C.A., Ancolio K., and Checler F. (2000) Wild type but not Parkinson's disease-related ala-53-Thr mutant α-synuclein protects neuronal cells from apoptotic stimuli. J. Biol. Chem. 275, 24,065-24,069.
62. Taylor J.P., Hardy J., and Fischbeck K.H. (2002) Toxic proteins in neurodegenerative disease. Science 14, 1991-1995.
63. Singleton A.B., Farrer M., Johnson J., et al. (2003) α-synuclein locus triplication causes Parkinson's disease. Science 302, 841.
64. Saleh A., Srinivasula S.M., Balkir L., Robbins P.D., and Alnemri E.S. (2000) Negative regulation of the Apaf-1 apoptosis by Hsp 70. Nat. Cell Biol. 2, 476-483.
65. Ravagnan L., Gurbuxani S., Susin S.A., et al. (2001) Heat-shock protein 70 antagonizes apoptosis-inducing factor. Nat. Cell Biol. 3, 839-843.
66. Auluck P.K., Edwin Chan H.Y., Trojanowski J.Q., Lee V.M.-Y., and Bonini N.M. (2002) Chaperonne suppression of α-synuclein toxicity in a drosophila model for Parkinson's disease. Science 295, 865-868.
67. Hashimoto M., Hsu L.J., Rockenstain E., Takenouchi T., Mallory M., and Masliah E. (2002) α-synuclein protects against oxidative stress via inactivation of the c-Jun N-terminal kinase stress-signaling pathway in neuronal cells. J. Biol. Chem. 277, 11,465-11,472.
68. Tanaka Y.I., Engelender S., Igarashi S., et al. (2001) Inducible expression of mutant α-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis. Hum. Mol. Genet. 10, 919-926.